Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Change in the number of shares and voting rights in Eniro

According to previously published information, Eniro AB (publ) ("Eniro" or the "Company") has in June 2018 completed a directed new share issue to the guarantor in the reverse share split in order to compensate for the number of equalization shares. The issue has resulted in a change in the total number of shares and voting rights in Eniro. The total number of shares and voting rights in Eniro increased during June with 5,042 ordinary shares of series A and voting rights of series A. As of June 29, 2018, the total number of shares in Eniro amounts to 66,784,611, of which 61 687 125

Nel ASA: Key information relating to subsequent offering to be carried out by Nel ASA

(Oslo, 29 June 2018) Reference is made to the stock exchange notice from Nel ASA (the "Company") on 28 June 2018, regarding a private placement of up to 90 million new shares in the Company (the "Private Placement") and a possible subsequent offering at the same subscription price as in the Private Placement (the "Subsequent Offering"). Date on which the terms and conditions of the potential repair issue were announced: 28 June 2018 Last day including right: 28 June 2018 Ex-date: 29 June 2018 Record date: 2 July 2018 Date of approval: 28 June 2018 Maximum number of new

CHANGE IN THE NUMBER OF SHARES AND VOTES IN KARO PHARMA

As of 29 June 2018, the last trading day of the month, the aggregate number of shares and votes in Karo Pharma AB amounts to 164,332,782. The increase in the number of shares and votes is attributable to the recently completed rights issue of 54,777,594 shares. The rights issue was announced on 4 April 2018. FOR FURTHER INFORMATION PLEASE CONTACT:Peter Blom, CEO, +46 (0) 70-655 56 98 or peter.blom@karopharma.se ABOUT KARO PHARMAKaro Pharma is a Specialty Pharmaceutical company, which develops and markets products for pharmacies as well as directly to healthcare sector. Karo Pharma

Increase of number of shares in Hansa Medical AB (publ)

As previously announced, the general meeting of Hansa Medical AB (publ) resolved to adopt a warrant program 2015-2019 on June 2, 2015. As part of the completion of the program, 205,000 ordinary shares have been issued. The company’s registered share capital and number of outstanding shares and votes have thus increased during the month of June 2018.As of today, the total number of registered and outstanding shares of Hansa Medical amounts to 38,413,386 whereof 38,083,125 are ordinary shares and 330,261 are Class C shares. As of today, the number of votes in Hansa Medical amounts to 38,116,

Change in number of shares and votes in Immunovia AB (publ)

The number of shares in Immunovia AB (publ) has changed due to the issue of 2,162,794 shares resolved by the Board in June.Following the registration of the new share issue with the Swedish Companies Registration Office and the introduction of the new shares in the share register held by Euroclear Sweden AB, the total number of shares and votes in Immunovia AB (publ) amounts to 19,480,853 shares.  This is information that Immunovia is obliged to make public pursuant to the Swedish Act on Trade in Financial Instruments. The information was submitted for publication, through the agency of

Increased number of shares and votes in Addnode Group

The number of shares and votes in Addnode Group AB (publ) has increased as a result of the directed new share issue resolved upon by the board on 18 June 2018. Through the directed new share issue the number of class B shares and votes in the company increased by 3,000,000 class B shares and 3,000,000 votes. At the last trading day of June there were in total 33,427,256 shares in the company (987,174 class A shares and 32,440,082 class B shares) and 42,311,822 votes. This information is information that Addnode Group AB (publ) is obliged to make public pursuant to the Financial

Turkish Aerospace Industries selects Siemens as a leading technology provider to transform the digital enterprise

· Leveraging a complete digital twin, Turkish Aerospace Industries will strengthen its innovation and increase competitivenessAnnounced today at a signing ceremony in Ankara, Turkey, Turkish Aerospace Industries has selected technology from Siemens PLM Software to implement a complete digital twin in the company’s manufacturing enterprise. Turkish Aerospace Industries has become Turkey's center of technology in design, development, modernization, manufacturing, integration and life cycle support of integrated aerospace systems, from fixed and rotary wing air platforms to unmanned aerial

Change in the number of shares and votes in AcadeMedia

The number of shares and votes in AcadeMedia has changed through issuance of 160,000 C shares carrying one tenth of a vote per share, i.e. in total 16,000 votes. All C shares are owned by the company. The share issue was resolved upon by the board of directors on 25 June 2018, on the basis of an authorization by the annual general meeting in the company held on 24 November 2017. The share issue forms part of the company’s long term incentive program, resolved upon at the annual general meeting. Prior to delivery of shares to qualifying participants at the end of the program, C shares

New number of shares and votes in Moberg Pharma AB (publ)

STOCKHOLM, June 29th, 2018, Moberg Pharma AB (OMX: MOB) announced that the total number of common shares in the company has increased to 17,703,762. The 263,000 newly issued shares are held by the company to secure its commitments under incentive programmes.As per 29 June 2018, the total number of shares in Moberg Pharma AB (publ) amounts to 17,703,762. All shares are common shares. The total number of votes are 17,703,762. The increase in the number of shares and votes results from an issue of 263,000 class C shares. The newly issued class C shares have been repurchased and, by virtue of

Change in number of shares and voting rights in NetEnt AB (publ)

Following completion of the automatic redemption program, the number of shares and votes in NetEnt AB (publ) has changed. The total number of shares in NetEnt now amounts to 240,130,860, of which 33,660,000 are class A shares and 206,470,860 are class B shares. The total number of voting rights amounts to 543,070,860 after the change. The share capital remains unchanged at SEK 1,205,456.9172 after the change in the number of shares. For additional information please contact:Therese Hillman, CEO of NetEntPhone: +46 8 5785 4500therese.hillman@netent.com Roland Glasfors,

Nobina Interim Report 1 March–31 May 2018

CONTINUED PROFITABLE GROWTH The first quarter ·  Net sales amounted to SEK 2,361 million (2,205), an increase of 7.1 per cent. ·  Operating profit amounted to SEK 104 million (95). ·  Profit before tax amounted to SEK 72 million (58). ·  Profit after tax amounted to SEK 54 million (41), and earnings per share totalled SEK 0.63 (0.46). ·  Cash flow from operations excluding changes in working capital was SEK 275 million (229).Significant events during the first quarter ·  Extension of two contracts with Ruter in Oslo and investment in electric buses. The extensions

Final offer price for Raketech’s listing set at SEK 30 per share – trading commences today

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.Raketech Group Holding plc (”Raketech”, the ”Company” or the “Group”), a Nordic leading online-based marketing company, today announces the outcome of the initial public offering of its shares and listing on Nasdaq First North Premier (the “Offering”). The Offering attracted strong interest both among Swedish and international

Successful Fogelberg Drill Stem Test

29 June 2018 Faroe Petroleum plc ("Faroe", "Faroe Petroleum", the "Company") Successful Fogelberg Drill Stem Test Faroe Petroleum, the independent oil and gas company focusing principally on exploration, appraisal and production opportunities in Norway and the UK, is pleased to announce a successful sidetrack well (6506/9-4 A) and successful production test ('Drill Stem Test', 'DST') following the drilling of the downdip appraisal well (6506/9-4 S) on Fogelberg located in the Norwegian Sea (Faroe 15%1). The Fogelberg discovery has now been successfully appraised confirming

Camurus has completed a directed share issue of 1.1 million shares, raising proceeds of approximately SEK 102 million

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL. Lund, Sweden — 29 June 2018 — Camurus AB (publ) (“Camurus” or the “Company”) (Nasdaq Stockholm, CAMX) is pleased to announce the completion of a directed share issue of approximately SEK 102 million. The board of directors of Camurus has, based on the authorization granted by the annual general meeting on 3 May 2018, resolved on a directed share issue of 1,

Increased number of shares and votes in Hemfosa

The number of shares and votes in Hemfosa Fastigheter AB has increased as a result of the directed new share issue resolved upon by the board on June 19, 2018. Through the directed new share issue the number of ordinary shares and votes in the company increased by 10,000,000 ordinary shares and 10,000,000 votes. At the last trading day of June there were in total 178,728,248 shares in the company (167,728,249 ordinary shares and 10,999,999 preference shares) and 168,828,248.9 votes.

Change in the total number of shares and votes in Recipharm AB (publ)

As of 29 June 2018, the total number of shares in Recipharm AB (publ) (“Recipharm”) amounts to 67,775,793 shares, divided into 15,222,858 shares of series A, 52,182,935 shares of series B and 370,000 shares of series D. The total number of votes in Recipharm as of 29 June 2018 amounts to 204,781,515. As previously announced by Recipharm, the number of shares and votes in Recipharm has increased as a result of a cash issue of 4,000,000 shares of series B raising SEK 508 million to Recipharm before issue costs, and an issue in kind of 558,261 shares of series B in the amount of

Change in the number of shares and votes in Nuevolution AB

Stockholm, 29 June 2018 – Nuevolution AB today announced that the number of shares and votes in the company amounts to 49,524,903 as per 29 June 2018. As a result of a directed issue executed on 24 May, the number of shares and votes increased with 6,666,667, from 42,858,236 to 49,524,903. Nuevolution AB does not hold any own shares. For more information, please contact: Alex Haahr Gouliaev, CEO Phone: +45 3913 0902 Email: ahg@nuevolution.com Henrik Damkjær Simonsen, CFO Phone: +45 3913 0947 Email: hs@nuevolution.com Information about Nuevolution AB (publ)

Smart Eye announces the opening of its first office in China

A growing demand for driver monitoring systems from outside Europe accentuates the need for increased international presence. Smart Eye today announces the opening of its first office in China with Chinese staffing already in place and operational.Because of increased global interest in driver monitoring technique and Smart Eye’s leading position in the field, the company has for a longer period of time been planning to establish an office in China. Smart Eye is today announcing that the first person has been hired to its new Chinese office that will be situated in Chongqing, in the Sichuan

Change in number of shares and votes in LeoVegas AB (publ)

The number of shares and votes in LeoVegas AB (publ) has changed as a result of the issue of 1,957,500 new shares in June through the exercise of warrants coupled to the incentive programme adopted at the 2015 Annual General Meeting. Following the exercise of warrants, the total number of shares and votes in LeoVegas AB (publ) as per 29 June 2018 is 101,652,970. The information in this release is such that LeoVegas AB (publ) is required to make public in accordance with the Financial Instruments Trading Act. The information was submitted, by the agency of the contact persons below,

Orkla ASA: Invitation to the presentation of Orkla's results for the second quarter of 2018 on Friday, 13 July 2018

Orkla will publish its second quarter 2018 results on Friday, 13 July at 07:00 CEST. The quarterly report and presentation material will be made available at this time at www.orkla.com.Telephone conference call at 08:00 CEST:President and CEO Peter A. Ruzicka and CFO Jens Staff will present the results in a telephone conference call at 08:00 CEST. The presentation and subsequent Q&A session will be held in English. The presentation may be viewed in a live webcast at view-w.tv/819-1460-19936/en or via www.orkla.no/investor/. To participate in the conference call, the following dial-in

BRAVIDA: CHANGE IN THE NUMBER OF VOTES IN BRAVIDA HOLDING AB

Stockholm – Today, Bravida Holding AB (BRAV) announces a change in the company’s number of votes as a result of the Board of Directors resolving to convert C-shares into ordinary shares for delivery to participants in its incentive program.In connection to the listing on Nasdaq Stockholm in 2015, approximately 250 employees were offered to participate in a long-term incentive plan ("LTIP 2015"). The program durated until the end of 2017 and allotment was made after the release of the first quarterly report for 2018. As a step in the allotment process, the Board of Directors of Bravida has

SpareBank 1 SR-Bank ASA (SRBANK); Invitation to attend the presentation of 2nd quarter 2018 accounts

SpareBank 1 SR-Bank's 2nd quarter 2018 accounts will be released on Wednesday August 8th. We would like to invite you to the following presentations:Single presentation SpareBank 1 SR-Bank ASAPresentation of 2nd Quarter 2018 accounts Wednesday August 8th 2018 in Olso, 08.15 am.Location: SpareBank 1 Markets, Olav V's gate 5Breakfast is served from 08.00 am. The presentation will be made by CEO Arne Austreid and CFO Inge Reinertsen. Joint presentationThe following banks together with the SpareBank 1 Gruppen AS are also inviting to a joint presentation of 2nd quarter 2018 accounts;

YIT to construct a new hotel in Turku, Finland

YIT Corporation Investor News June 29, 2018 at 8:30 A.M.YIT, Rausanne Oy and Turun Osuuskauppa (S Group, Turku Cooperative Society) together have agreed to construct a new hotel in Kupittaa, Turku, Finland. The value of the transaction is approximately EUR 30 million. The project will be entered in the order backlog for the second quarter of the year. The 9-storey Sokos hotel will have around 200 rooms and will accommodate nearly 500 guests. The new hotel will be operated by Turun Osuuskauppa and owned by Rausanne Oy. “Until now, the Kupittaa area has been lacking in hotel services.

There are no items matching the current filter
There are no more items matching the current filter
Back to top